The global assisted reproductive technology market size was USD 26 Bn in 2022 and is likely to reach USD 43.5 Bn by 2031, expanding at a CAGR of 5.95% during 2023–2031. The market is driven by the rising rate of infertility, an increase in the cases of polycystic ovarian syndrome (PCOS), and growing awareness regarding surrogacy and infertility treatment.
Increasing rate of infertility due to a surge in the cases of PCOS (Polycystic ovary syndrome), PCOD (Polycystic Ovarian Disease), and obesity, among others is amplifying the requirement for fertility treatments. This, in turn, has created a strong demand for assisted reproductive technology in the healthcare industry. These treatments involve procedures from artificial insemination to the use of software and imaging systems to monitor the growth of embryos. Such treatments are assisting millions of couples in having a child, as they have a higher success rate and reduced possibilities of miscarriage.
- As per the World Health Organization (WHO), around 48 million couples and 186 million individuals were diagnosed with infertility in 2020.
Assisted reproductive technology (ART) refers to the medical procedure that helps in conceiving a child in cases of infertility issues. It is typically the manipulation of sperm, eggs, or embryos in a laboratory. The ART process involves the surgical removal of eggs from the ovaries, combining it with the sperm in a laboratory, returning it to the woman’s body, or donating it to another woman.
Assisted reproductive technology includes techniques such as in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and embryo cryopreservation, among others. While these technologies are very successful, they are highly expensive. However, they do provide a chance to have a baby, in cases where it is not possible naturally or when people want to have a baby at a time of choice.
- As per the Centers for Disease Control and Prevention (CDC), around 2% of all infants born in the United States each year are conceived using assisted reproductive technology.
The market report finds that the COVID-19 pandemic affected the market negatively owing to the drop in patient volume visiting hospitals and clinics for non-life-threatening health treatments. Due to the fear of COVID-19 infection and lockdown restrictions, most people opted to stay at home and avoided visiting hospitals for anything non-critical or not time-sensitive reasons.
Assisted Reproductive Technology Market Dynamics
Major Drivers
Increasing prevalence of PCOS and infertility is expected to drive the market during the forecast period. The number of infertility cases has increased globally over the years due to several factors including unhealthy lifestyles, smoking & pollution, growing stress, and obesity, among others. Furthermore, several medical treatments create unfavorable conditions in the body for fertility, such as chemotherapy.
Growing awareness about infertility treatments and surrogacy is anticipated to have a positive impact on market growth owing to the increased acceptance and understanding of these procedures. As more people become aware of the benefits and the treatment options available to them, they are more likely to seek out assisted reproductive technology services. Furthermore, the advancements in treatment technology and medical expertise have improved success rates, thereby encouraging people to opt for these treatments.
Existing Restraints
High cost and health risks associated with assisted reproductive technology procedures are expected to limit the market growth. These reproductive treatments are highly expensive and make it difficult for low- to mid-income patients to afford them. In addition, the high estrogen levels caused by high-stimulation IVF often increase the risk of premature birth and undergrown infants. Further, it can also cause other health complications such as vaginal bleeding, nausea, headache, and bloating.
- Based on a report published by the National Health Institute in 2022, it was found that the greatest risks associated with IVF treatment for women are placental complications and uterine bleeding. The biggest risks that infants have in IVF treatment include extremely low birth rates and premature delivery.
Emerging Opportunities
Extensive research and technological advancements in the development of various fertilization techniques are projected to create growth opportunities for the market. Various innovative fertilization techniques such as zygote intra-fallopian transfer, gamete intra-fallopian transfer, artificial insemination, and in vitro fertilization (IVF) provide patients with multiple options for safe childbirth. The IVF procedure alone has been shown to have a high success rate for embryo transfer.
- As per one of the reports published by the National Institute of Health in 2022, it has been found that owing to the sociodemographic advancements of technology, the demand for IVF has considerably increased over the years. This shows the changing patterns toward acceptance of assistive technology for conceiving children among the majority of the population.
- In February 2021, a prominent life science technology company, TMRW Life Sciences, made the announcement of the launch of the world's first automated solution for cryo specimen management. It has been developed for the eggs and embryos used in IVF procedures.
Scope of the Assisted Reproductive Technology Market Report
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Assisted Reproductive Technology Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Product (Instruments, Reagent & Media, Disposable, and Accessories), Technique (In-Vitro Fertilization Technique, Frozen Embryo Transfer Technique, Artificial Insemination Technique, and Other Techniques), Procedure Type (Fresh Non-Donor, Frozen Non-Donor, Frozen Donor, and Fresh Donor), End-user (Fertility Clinics, Clinical Research Institutes, Surgical Centers, and Hospitals)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Apollo Hospitals Group; Bloom Fertility Centre; California Cryobank; CARE Fertility; Carolinas Fertility Institute; European Sperm Bank; INVO Bioscience; Monash IVF Group; Genea Pty Limited; and FUJIFILM Irvine Scientific.
|
Assisted Reproductive Technology Market Segment Insights
Product Segment Analysis
Based on product, the assisted reproductive technology market is divided into instruments, reagent & media, disposable, and accessories. The instruments segment is anticipated to hold a large revenue share of the market during the projection period as they play a crucial role in performing procedures such as IVF and embryo transfer. The instruments enable the precise manipulation and handling of reproductive cells and tissues, thereby contributing to the improved success rates of the procedure.
Technology Segment Analysis
On the basis of technique, the global market is segregated into in-vitro fertilization technique, frozen embryo transfer technique, artificial insemination technique, and other techniques. The in-vitro fertilization segment is projected to register a robust CAGR during the forecast period due to its high success rate and innovative techniques. Modern healthcare can now use the time-lapse imaging system for obtaining the image of the egg division. The use of such technologies in IVF treatment makes it highly reliable and increases its demand among patients.
The frozen embryo transfer (FET) segment is anticipated to expand at a significant pace in the market owing to its high success rate and prevalence. It provides the patient an opportunity to try again after an unsuccessful IVF cycle at a comparatively low cost. It eliminates a few steps out of the fresh IVF, which leads to faster results for the patient.
Procedure Type Segment Analysis
On the basis of the procedure type, the assisted reproductive technology market is classified as fresh non-donor, frozen non-donor, frozen donor, and fresh donor. The fresh non-donor segment is projected to register a robust growth rate as it has a high success rate due to the use of fresh embryos or eggs. Moreover, the increasing prevalence of infertility problems is also likely to boost the growth of this segment.
The frozen non-donor segment is expected to register a considerable CAGR during the forecast period due to its low cost in comparison to the cycles that use fresh embryos or eggs. Furthermore, the transfer of frozen embryos allows women additional recovery time between the retrieval and transfer of the embryos.
End-User Segment Analysis
Based on end-user, the assisted reproductive technology market is divided into fertility clinics, clinical research institutes, surgical centers, and hospitals. The fertility clinics segment is expected to generate a major revenue share of the market due to the comprehensive range of infertility treatments and the availability of doctors and professionals who specialize in reproductive technologies. Moreover, these clinics provide personalized care and a supportive environment for the people opting for these procedures.
The hospitals segment is expected to expand at a significant growth rate as they provide multidisciplinary teams and access to a wide range of medical services. The integration of fertility services along with other healthcare facilities provides a convenient one-stop solution for patients seeking any type of fertility treatment.
Regional Outlook
In terms of region, the global assisted reproductive technology market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Europe is expected to dominate the market during the projection period due to its well-established healthcare analytics system and infrastructure. Furthermore, the high prevalence of fertility issues is increasing awareness and acceptance of infertility treatments.
-
For instance, as per the European Society of Human Reproduction and Embryology, approximately 140,909 assisted reproductive treatment cycles are performed every year in Spain alone.
North America is projected to exhibit considerable growth in the demand for assisted reproductive technology treatments as it has cutting-edge medical science facilities and specialized clinics that offer a wide range of medical treatments. Moreover, factors such as delayed parenthood, growing societal acceptance of alternative reproductive options, and increased cases of infertility are expected to have a significant impact on the growth.
Segments
The assisted reproductive technology market has been segmented on the basis of
Product
- Instruments
- Reagent & Media
- Disposable
- Accessories
Technique
- In-Vitro Fertilization Technique
- Frozen Embryo Transfer Technique
- Artificial Insemination Technique
- Other Techniques
Procedure Type
- Fresh Non-Donor
- Frozen Non-Donor
- Frozen Donor
- Fresh Donor
End-user
- Fertility Clinics
- Clinical Research Institutes
- Surgical Centers
- Hospitals
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Apollo Hospitals Group
- Bloom Fertility Centre
- California Cryobank
- CARE Fertility
- Carolinas Fertility Institute
- European Sperm Bank
- INVO Bioscience
- Monash IVF Group
- Genea Pty Limited
- FUJIFILM Irvine Scientific
Competitive Landscape
Key players competing in the global assisted reproductive technology market are Apollo Hospitals Group; Bloom Fertility Centre; California Cryobank; CARE Fertility; Carolinas Fertility Institute; European Sperm Bank; INVO Bioscience; Monash IVF Group; Genea Pty Limited; Inception Fertility LLC; Virtus Health; and FUJIFILM Irvine Scientific.
These major companies of the ART market have adopted several development strategies including acquisitions, collaboration, partnerships, mergers, and production expansion to tap into the untapped regions and expand their consumer base worldwide. The ongoing investments and research & development activities are likely to further the developments in assisted reproductive technology solutions space. For instance,
- In June 2022, Inception Fertility launched HavenCryo, a long-term storage solution for reproductive tissue and cryopreservation. The company has expanded its ecosystem by providing patients with a unique experience that includes technology for assisted reproduction.
- In August 2021, Virtus Health Ltd. acquired Healius Limited-owned Adora Fertility and three-day hospitals for USD 45 million. Virtus Health is an Australian company that facilitates assisted reproductive technology. This acquisition strengthens the portfolio and helps Virtus Health get an edge over its competitors.
Request For Customization
Enquiry Before Buying
Speak With Analyst
